Axolotl Biologix CEO to attend Arizona Bioscience Week, September 18th through 23rd

Axolotl Biologix CEO, Bob Maguire will be attending the Arizona Bioscience Week, sponsored by the Arizona Bioindustry Association (AZBio). There are events and breakout session throughout the week and Bob will be meeting with other leaders in the biologics, research, and science industries. Most of the events will be held at the Phoenix Downtown Sheraton Hotel and the Phoenix Convention Center, the week of September 18th through the 23rd. The highlight of the week will be the AZBio Awards on Wednesday, September 22nd, with Governor Doug Ducey addressing the attendees.

About AZBio 

AZBio is a not-for-profit, 501 (c) 6 trade association promoting the growth of Arizona bioscience companies.

The Association is comprised of Member organizations in business, research and education, economic development, government, and other professions involved in the biosciences.  As the unified voice of the bioscience industry in Arizona, AZBio strives to make Arizona a place where bioscience organizations can grow and succeed.

We accomplish this by…

  • creating a forum for the bioscience community to join together to engage, connect and collaborate.

  • educating policy makers and the public about the benefits of our industry to the community.

  • advancing the economic interests of individual organizations as well as the sector as a whole.

As the state affiliate in Arizona of the Biotechnology Industry Organization (BIO), the preeminent national association for biotechnology companies, and of AdvaMed, the largest association representing manufacturers of medical devices, diagnostic products and medical information systems, AZBio has access to information, contacts, resources, cost saving programs, and access to a global bioscience community to which we can connect Member companies.

About Axolotl Biologix

Axolotl Biologix, Inc. is a biologics company that develops and manufactures human tissue regenerative medicine products for orthopedic, wound care, podiatric, and cosmetic conditions.  The Company’s lead product is its AxoBioFluid™, which is an amniotic allograft cryopreserved liquid that advances soft tissue repair, replacement, and reconstruction.  The Company’s vision is to be an innovative leader in regenerative medicine through research, technology, and clinical application.  For more information, please visit Axolotl Biologix’ website at www.axobio.com.

SOURCE Axolotl Biologix, Inc.